| Mireille Bitar, MD | |
|
1 Robert Wood Johnson Pl, Meb 212, New Brunswick, NJ 08901-1928 | |
| (732) 235-8120 | |
| Not Available |
| Full Name | Mireille Bitar |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1 Robert Wood Johnson Pl, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295979003 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 25MA08387000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mireille Bitar, MD 1 Robert Wood Johnson Pl, Meb 212, New Brunswick, NJ 08901-1928 Ph: () - | Mireille Bitar, MD 1 Robert Wood Johnson Pl, Meb 212, New Brunswick, NJ 08901-1928 Ph: (732) 235-8120 |
News Archive
HHS Secretary Kathleen Sebelius today announced $130.8 million in grants to strengthen and expand the health professions workforce. Six areas are targeted: primary care workforce training, oral health workforce training, equipment to enhance training across the health professions, loan repayments for health professionals, health careers opportunity programs for disadvantaged students, and patient navigator outreach and chronic disease prevention in health disparity populations.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
The U.S. Centers for Disease Control (CDC) released an alarming new report on Monday. According to the CDC report almost 50% of the adult population of the United States have chronic conditions which could lead to heart disease. The pre-existing diagnosed conditions included high blood pressure, high cholesterol and diabetes.
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.
› Verified 1 days ago
Billie S Fyfe Kirschner, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, Robert Wood Johnson University Hospital New Brunswick, New Brunswick, NJ 08901 Phone: 732-937-8651 | |
Peter Yurchenco, Pathology Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, Robert Wood Johnson University Hospital - New Brunswick, New Brunswick, NJ 08901 Phone: 732-937-8651 | |
Richard Herbert Siderits, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, Robert Wood Johnson University Hospital - New Brunswick, New Brunswick, NJ 08901 Phone: 732-937-8651 | |
Dr. Tamar Chana Brandler, MD, MS Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl Fl 3, New Brunswick, NJ 08901 Phone: 732-253-3413 | |
Dr. Marvin Lessig, D.O. Pathology Medicare: Not Enrolled in Medicare Practice Location: 167 New St, New Brunswick, NJ 08901 Phone: 732-220-7028 Fax: 732-220-7199 | |
Dr. Karel Raska Jr., MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Avenue, New Brunswick, NJ 08903 Phone: 732-743-8504 Fax: 732-828-3858 | |
Dr. Benjamin Heath Durham, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 195 Little Albany St Rm 4557, New Brunswick, NJ 08901 Phone: 732-235-9718 |